Abbreviated Magnetic Resonance Imaging for HCC Surveillance.
作者信息
Vietti Violi Naik, Fowler Kathryn J, Sirlin Claude B, Taouli Bachir
机构信息
Department of Radiology Lausanne University Hospital Lausanne Switzerland.
Liver Imaging Group Department of Radiology UC San Diego Medical Center San Diego CA.
出版信息
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):133-138. doi: 10.1002/cld.1016. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Abbreviated Magnetic Resonance Imaging for HCC Surveillance.用于肝癌监测的简化磁共振成像
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):133-138. doi: 10.1002/cld.1016. eCollection 2021 Mar.
2
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.非对比磁共振成像与超声检查用于肝细胞癌监测的比较（MIRACLE-HCC）：一项前瞻性随机试验的研究方案。
BMC Cancer. 2018 Sep 24;18(1):915. doi: 10.1186/s12885-018-4827-2.
3
Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.用于肝细胞癌监测的缩短肝胆期钆塞酸增强 MRI 对每位患者的诊断准确性。
AJR Am J Roentgenol. 2015 Mar;204(3):527-35. doi: 10.2214/AJR.14.12986.
4
Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.超声造影每半年 1 次与非增强磁共振成像每年 1 次作为肝硬化患者肝癌监测工具的比较（MAGNUS-HCC）：研究方案。
BMC Cancer. 2017 Dec 21;17(1):877. doi: 10.1186/s12885-017-3819-y.
5
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.钆塞酸增强简化 MRI 对肝细胞癌筛查具有高度准确性。
Eur Radiol. 2020 Nov;30(11):6003-6013. doi: 10.1007/s00330-020-07014-1. Epub 2020 Jun 25.
6
Can Abbreviated Cardiac Magnetic Resonance Imaging Adequately Support Clinical Decision Making After Repair of Tetralogy of Fallot?简化心脏磁共振成像能否充分支持法洛四联症修复术后的临床决策？
Pediatr Cardiol. 2019 Mar;40(3):616-622. doi: 10.1007/s00246-018-2035-0. Epub 2018 Dec 11.
7
Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.磁共振成像在肝硬化高危患者肝癌监测中具有成本效益。
Hepatology. 2019 Apr;69(4):1599-1613. doi: 10.1002/hep.30330. Epub 2019 Feb 25.
8
Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program.肝硬化患者纳入肝细胞癌监测计划后的异常影像学表现的频率和结局。
Liver Transpl. 2019 Mar;25(3):369-379. doi: 10.1002/lt.25398.
9
The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma.钆塞酸二钠增强磁共振成像在肝细胞癌术后复发监测中的应用
Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666.
10
Surveillance and diagnosis of hepatocellular carcinoma: A systematic review.肝细胞癌的监测与诊断：一项系统综述。
World J Clin Cases. 2019 Aug 26;7(16):2269-2286. doi: 10.12998/wjcc.v7.i16.2269.
引用本文的文献
1
Comparative Analysis of Imaging Modalities for Surveillance on Outcomes in Patients With Hepatocellular Carcinoma.肝细胞癌患者预后监测成像方式的比较分析
Gastro Hep Adv. 2025 May 16;4(9):100704. doi: 10.1016/j.gastha.2025.100704. eCollection 2025.
2
LI-RADS: Current Status and Future Directions.LI-RADS：现状与未来方向。
Korean J Radiol. 2024 Dec;25(12):1039-1046. doi: 10.3348/kjr.2024.0161.
3
MRI paraspinous skeletal muscle enhancement: A potential imaging biomarker for assessing clinical liver cirrhosis severity.MRI 脊柱旁骨骼肌强化：评估临床肝硬化严重程度的潜在影像学生物标志物。
PLoS One. 2024 Aug 22;19(8):e0308520. doi: 10.1371/journal.pone.0308520. eCollection 2024.
4
Abbreviated magnetic resonance imaging in hepatocellular carcinoma surveillance: A review.肝癌监测中的简化磁共振成像：综述。
Indian J Gastroenterol. 2024 Dec;43(6):1090-1098. doi: 10.1007/s12664-023-01511-z. Epub 2024 Mar 9.
5
Clinical Significance of Liver MR Imaging.肝脏磁共振成像的临床意义。
Magn Reson Med Sci. 2023 Apr 1;22(2):157-175. doi: 10.2463/mrms.rev.2022-0100. Epub 2023 Feb 1.
本文引用的文献
1
Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience.钆塞酸增强简化MRI用于肝细胞癌监测：初步经验
Radiol Imaging Cancer. 2019 Nov 29;1(2):e190010. doi: 10.1148/rycan.2019190010. eCollection 2019 Nov.
2
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.钆塞酸增强简化 MRI 对肝细胞癌筛查具有高度准确性。
Eur Radiol. 2020 Nov;30(11):6003-6013. doi: 10.1007/s00330-020-07014-1. Epub 2020 Jun 25.
3
Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.对比在初诊肝细胞癌患者中应用钆塞酸二钠行非对比 MRI 和简化 MRI 的诊断性能：一项肝细胞癌监测的模拟研究。
Eur Radiol. 2020 Aug;30(8):4150-4163. doi: 10.1007/s00330-020-06754-4. Epub 2020 Mar 12.
4
Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound.非增强磁共振成像作为肝细胞癌的监测工具：与超声的比较。
J Hepatol. 2020 Apr;72(4):718-724. doi: 10.1016/j.jhep.2019.12.001. Epub 2019 Dec 10.
5
Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.肝硬化中肝细胞癌的检测：对比增强 CT 与 MRI 联合细胞外对比剂及钆塞酸二钠的诊断性能比较。
Eur Radiol. 2020 Feb;30(2):1020-1030. doi: 10.1007/s00330-019-06458-4. Epub 2019 Oct 31.
6
Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.在循环无细胞 DNA 中进行 5-羟甲基胞嘧啶的全基因组图谱绘制，作为一种用于肝细胞癌早期检测的非侵入性方法。
Gut. 2019 Dec;68(12):2195-2205. doi: 10.1136/gutjnl-2019-318882. Epub 2019 Jul 29.
7
Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.简化方案筛查磁共振成像与完整方案诊断磁共振成像在肝硬化患者中检测肝细胞癌的比较：一项使用LI-RADS v2018的等效性研究
J Magn Reson Imaging. 2020 Feb;51(2):415-425. doi: 10.1002/jmri.26835. Epub 2019 Jun 18.
8
Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.肝细胞癌监测与诊断成像的成本效用分析
AJR Am J Roentgenol. 2019 Jul;213(1):17-25. doi: 10.2214/AJR.18.20341. Epub 2019 Apr 17.
9
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.GALAD 评分系统在肝细胞癌检测中的应用与肝脏超声比较及 GALADUS 评分的提出。
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):531-538. doi: 10.1158/1055-9965.EPI-18-0281. Epub 2018 Nov 21.
10
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南：肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
Zotero 插件